lobbying_activities: 2869286

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2869286	e2a75fd5-74af-414d-9d03-5b8796477631	Q3	WEST FRONT STRATEGIES LLC	401103493	VIATRIS INC	2022	third_quarter	CPT	Issues related to Inter Partes Review and patent policy generally; Preserving Access to Affordable Generics and Biosimilars Act, S. 1428, H.R. 2891; Affordable Prescriptions for Patients Act, S.1435, H.R. 2873; Restoring the America Invents Act, S. 2891.	HOUSE OF REPRESENTATIVES,SENATE	70000		0	0	2022-10-17T17:41:20-04:00